Cargando...
Additional antianginal and anti‐ischemic efficacy of mibefradil in patients concomitantly treated with long‐acting nitrates for chronic stable angina pectoris
Background: Mibefradil, a newly approved antihypertensive and antianginal drug, is the first member of a new class of calcium antagonists (CAs), the tetralol derivatives, that selectively blocks T‐type Ca(2+) channels in contrast to classical CAs which, at therapeutic concentrations, block only L‐ty...
Gardado en:
| Publicado en: | Clin Cardiol |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Wiley Periodicals, Inc.
2009
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6656231/ https://ncbi.nlm.nih.gov/pubmed/9669057 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.4960210707 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|